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Abstract  
Background. The current method for cell line authentication is short tandem repeat PCR 
(STR-PCR) -based genotyping involving co-amplification of a panel of STR loci by 
multiplex PCR and the downstream fragment length analysis (FLA), usually performed by 
capillary electrophoresis. FLA by capillary electrophoresis is time-consuming and can be 
expensive as the facilities are generally not accessible for many research laboratories. 
Methods. In the present study, a microfluidic electrophoresis system, the Agilent 2100 
Bioanalyzer, was utilised to analyse the STR-PCR fragments from 10 human genomic loci of 
a number of human cell lines, including 6 gliomas, 1 astrocyte, 1 rhabdomyosarcoma, 1 
primary lung cancer and 1 lung brain metastatic cancer; and this was compared to the 
standard method, i.e. capillary electrophoresis, using the Applied Biosystems 3130xl Genetic 
Analyzer. Results. The microfluidic electrophoresis method produced highly reproducible 
results with good sensitivity in sizing of multiple PCR fragments and each cell line 
demonstrated a unique DNA profile. Furthermore, DNA fingerprinting of samples from 5 
different passage numbers of the same cell line showed excellent reproducibility when FLA 
was performed with the Bioanalyzer, indicating that no cross-contamination had occurred 
during the culture period. Conclusion. This novel application provides a straightforward and 
cost-effective alternative to STR-based cell line authentication. In addition, this application 
would be of great value for cell bank repositories to maintain and distribute precious cell 
lines. 
Keywords: brain tumour cell authentication, STR profiling, DNA fingerprinting, 
microfluidics. 
Introduction 
The importance of cell line authentication has been well recognised by the research 
community and recently a list of 360 cross-contaminated and misidentified cell lines has been 
published, with the list being updated when necessary.
1
 At present the widely proposed 
technology for human cell line authentication is short tandem repeat PCR (STR-PCR) -based 
DNA genotyping and the standard method for analysing STR fragments, i.e. fragment length 
analysis (FLA), is capillary electrophoresis.
2-5
 There are a number of commercially available 
STR kits commonly used that provide convenient multiplex PCR amplification of the 
markers.
4
 The downstream FLA is, however, normally done by capillary electrophoresis 
which requires state-of-the-art facilities and properly trained specialists to analyse the data 
obtained, resulting in outsourcing of the cell authentication service for the majority of 
research laboratories. We were interested in exploring the possibility of using other 
electrophoresis platforms for FLA, e.g. the Agilent 2100 Bioanalyzer that is a microfluidics-
based Lab-on-Chip system for sizing and quantification of DNA, RNA, proteins and cells.
6-9
 
It also provides quality control of DNA, RNA and protein samples in a broad range of 
molecular assays.
10-12
 Recently the Bioanalyzer has been employed to resolve STR fragments 
in forensic samples as well as to identify fish species based on their restriction fragment 
length polymorphism pattern.
13,14
   
Our Cellular & Molecular Neuro-oncology Research Laboratories at the University of 
Portsmouth acts as the brain tumour cell culture repository for the South of England Brain 
Tumour Alliance (SEBTA), a network formed in 2011 by 7 regional centres in the South of 
England that are involved in diagnosis, treatment and research in the field of Neuro-oncology 
(http://sebta.org). With its clearly identified strategic aims SEBTA promotes and facilitates 
increased collaboration between those centres, including sharing valuable tissues and cell 
lines. Therefore, apart from our own group, we are responsible for the authentication of cell 
lines that are distributed across the SEBTA centres by our brain tumour cell culture 
repository, and it is critical for us to establish an efficient workflow for the routine cell 
authentication tests. For that purpose, in the present study we investigated the potential of this 
microfluidic system in STR genotyping of human brain tumour cell lines, exploiting its 
capacity of DNA fragment separating and sizing. The microfluidics-based electrophoresis 
proved to be an effective and simple method for FLA in replacement of capillary 
electrophoresis. In addition, it created accurate and reproducible DNA profiling data for the 
cell lines studied, offering an efficient and reliable tool for our routine cell line genotyping 
test.      
       
 
Materials and methods 
Cell lines 
All primary cell lines were derived from patient biopsy materials under Ethics permissions 
LREC 00-173 or KCH 11-094 or 11/SC/0048 in accordance with the National Research 
Ethics Service (NRES). These cell lines in addition to four established commercially 
available cell lines were used in the first part of the DNA profiling studies. The primary 
glioma cell lines included a grade II astrocytoma UP-016 / Passage (P)2, a grade III 
astrocytoma UP-032 (P5), three grade IV glioblastoma multiforme (GBM) cell lines, IN699 
(P17), UP-019 (P9) and UP-029 (P5). One primary lung brain metastatic cell line, UP-024 
(P4), was also included in this study. Commercially available cell lines analysed were: the 
GBM cell line SNB-19 (DSMZ – German Collection of Microorganisms and Cell Cultures; 
P63), the rhabdomyosarcoma cell line TE-671 (American Type Culture Collection (ATCC); 
P22), the human lung carcinoma cell line NCI-H1299 (American Type Culture Collection 
(ATCC); P25) and the normal human astrocyte cell line CC2565 (Lonza Biologics; P10). 
Cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM) (Invitrogen) with 10% 
foetal calf serum (FCS) (Sigma-Aldrich) with the exception of NCI-H1299 cells that were 
cultured in RPMI-1640 medium (Sigma-Aldrich).   
To monitor potential changes (in particular cross-contamination) in cell lines over 
long-term culture, UP-029 and another biopsy-derived GBM cell line, SEBTA-003 (cultured 
in 10%FCS/DMEM), were genotyped in the second part of these studies.  Cells were cultured 
for 5 continuous passages with 5-passage interval (i.e. P10, P15, P20, P25 and P30 of UP-
029; P8, P13, P18, P23 and P28 of SEBTA-003). 
 
STR-PCR 
Genomic DNA was extracted from cultured cells using the QIAamp DNA Mini Kit (Qiagen). 
The STR-based multiplex PCR was carried out with the StemElite ID System (Promega) 
according to the manufacturer’s protocol.15 DNA amplification was set up in a final volume 
of 25μl reaction, including 1×Enzyme Mix, 1×Primer Pair Mix and 2ng of template DNA. 
PCR was performed on the MyCycler Thermal Cycler (Bio-rad) using the thermal cycling 
programme recommended for the Applied Biosystems GeneAmp PCR System 9600 Thermal 
Cycler, according to the StemElite ID System Manual (Promega).
15
 The step-by-step thermal 
cycling protocol is as follows: step 1: 96°C for 2 minutes; step 2: 94°C for 30 seconds; step 3 
(×10 cycles): ramp 60 seconds to 60°C and hold for 30 seconds, then ramp 50 seconds to 
70°C and hold for 45 seconds; step 4: 90°C for 30 seconds; step 5 (×22 cycles): ramp 60 
seconds to 60°C and hold for 30 seconds, then ramp 50 seconds to 70°C and hold for 45 
seconds; step 6: 60°C for 30 minutes. The primers of the StemElite ID System Kit amplify 9 
human STR loci, including D21S11, TH01, TPOX, vWA, CSF1PO, D16S539, D7S820, 
D13S317 and D5S818, as well as Amelogenin for gender identification. These markers are 
selected from the set of core STR loci that has been approved by the human identity testing 
community.
4,16
 STR-PCR was performed in 3 independent experiments for all cell lines in the 
first part of the studies (Exp.1, 2 and 3), whereas one STR-PCR experiment was carried out 
for 5 continuous passages of UP-029 and SEBTA-003, respectively, in the cross-
contamination test study. A negative PCR reaction was included in each of the experiments 
where template DNA was replaced with water.        
 
FLA  
Amplified alleles in the STR-PCR products were separated on the Agilent 2100 Bioanalyzer 
(Agilent Technologies) with the Agilent DNA 1000 Kit (Agilent Technologies), according to 
the standard protocol with slight modifications.
17
 In essence, the DNA chip was first primed 
with 9μl of the gel-dye mixture then 3μl of the PCR product was added to each of the 12 
sample wells along with 3μl of the internal marker (Agilent Technologies). One microlitre of 
the Agilent DNA 1000 ladder (Agilent Technologies), used as a sizing standard, was loaded 
into the ladder well with 5μl of the internal marker. After electrophoresis, the amplified 
alleles from each sample were analysed using the manufacturer's software, i.e. 2100 Expert, 
provided with the instrument; the size of each fragment was determined based on the ladder 
and internal standards. In addition, the STR markers were identified based on their size 
ranges.
15
 FLA was done with the Bioanalyzer for all samples from 3 independent STR-PCR 
experiments (Exp.1, 2 and 3). In comparison, samples from the first experiment (Exp.1) were 
sent to Eurofins MWG Operon (http://www.eurofinsgenomics.eu) and analysed using 
standard procedures of capillary electrophoresis on the Applied Biosystmes (ABI) 3130xl 
Genetic Analyzer, as described in the service information document (Eurofins MWG 
Operon).
18
 The relevant negative sample was also included in each of the FLA analyses as a 
control.    
 
Results 
DNA profiling of cell lines by microfluidics-based electrophoresis and capillary 
electrophoresis  
To assess the application of the microfluidics-based electrophoresis method in STR-based 
DNA profiling of human cell lines, amplified STR fragments of the above 10 cell lines from 
the first experiment (Exp.1) were separated and analysed by both microfluidic and capillary 
electrophoresis. The former was performed in our laboratory using the Agilent DNA 1000 Kit 
and the data were analysed by the Agilent 2100 Expert software; the latter by Eurofins 
MWG’s FLA service using the ABI 3130xl Genetic Analyzer as recommended for the 
StemElite ID System.
15
 Amplified STR fragments from all 10 cell lines were successfully 
separated by the Bioanalyzer as demonstrated by the representative electropherograms (Fig. 
1A & B). Although DNA fragment sizing was on average around 20bp larger than that 
obtained from capillary electrophoresis, likely due to the dye-labelled PCR primers which 
had incorporated into the fragments and consequently reduced the migration speed of those 
fragments, both sets of data were highly comparable in terms of the DNA profiles of the cell 
lines studied (Table 1A). There were differences in several of the STR markers when 
comparing these two methods.  When analysing the STR marker D21S11, 4 of the 10 cell 
lines using the microfluidic method failed to detect the heterozygous alleles compared to 
capillary electrophoresis (shaded cells in Table 1A). The STR markers, D5S818, vWA, 
TPOX and CSF1PO, showed homozygous alleles in 10% (1/10) of the cell lines where 
capillary electrophoresis revealed heterozygosity of the associated marker in those cell lines 
(shaded cells in Table 1A). On the contrary, the microfluidic system was highly consistent in 
terms of analysing homozygous SRT markers and the homozygosity matched 100% between 
those two methods (Table 1A).  In one cell line (UP-029), there was a discrepancy in the 
sizes of two alleles of D7S820 between the methods, with 1bp difference in the microfluidic 
method whereas there was 16bp by capillary electrophoresis (underlined cells in Table 1A). 
In total, 92% (92/100) of the analysed markers showed excellent similarity between the 
Bioanalyzer and capillary electrophoresis in terms of fragment sizing. Importantly, both 
microfluidic and capillary electrophoresis revealed a unique DNA profile of each cell line, 
presented by fragment sizing for the former (Table 1A) and by the internationally recognised 
standard for the latter (Table 1B). 
The DNA profiles of NCI-H1299 and TE-671 in the present study matched the ones 
published by ATCC
19
 and in the DSMZ database respectively (Table 1C). While previous 
STR analysis at ATCC revealed that the human GBM cell line SNB-19 had an identical 
profile to U-373 MG, another GBM cell line, which led to SNB-19 being discontinued by 
ATCC.
20
 As mentioned above, our laboratory obtained the SNB-19 from the DSMZ – 
German Collection of Microorganisms and Cell Cultures and this cell line was included in the 
DNA profiling study to determine if our SNB-19 cell line had been cross-contaminated. Our 
data confirmed that the SNB-19 cell line in our cell bank was not cross-contaminated with U-
373 MG as reported by ATCC, based on the comparison between STR profiles of our SNB-
19 cell line and the reported U-373 MG (Table 1C).
21
 According to the DSMZ data sheet, 
SNB-19 is a “subclone” of the human GBM cell line U-251 MG.22 This conclusion is 
supported by previous studies indicating that those two cell lines carry 96% genotype 
similarity and identical genomic variants, i.e. TP53, CDKN2A and PTEN mutations,
16,23
 
although SNB-19 and U-251 MG have diverged at the karyotypical level.
24  
Interestingly, 
when STR matching analysis was performed using DSMZ’s online tool for the SNB-19 cell 
line included in the present study, the result shows that our SNB-19 has the identical STR 
profile to those for U-251 MG and SNB-19 in the DSMZ database (Table 1C). Hence the 
SNB-19 cell line cultured in our laboratories has 100% genotype similarity to both cell lines 
(i.e. U-251 MG and SNB-19) held at DSMZ. Our data also provide further evidence for the 
previous observation that SNB-19 is a derivative of U-251 MG. In addition, the STR profiles 
of three commercial cell lines, NCI-H1299, SNB-19 and TE-671, obtained by capillary 
electrophoresis in our study were identical to those in published databases (Table 1C), 
indicating good reproducibility of the conventional method.    
 
Reproducibility of FLA using a microfluidics-based electrophoresis system 
In order to evaluate the reproducibility of this alternative electrophoresis platform in the 
application of STR fragment length analysis, three independent experiments were carried out 
with multiplex PCR amplification and fragment separation/sizing for the 10 cell lines in the 
DNA profiling study, using the same DNA sample of each cell line. Except D5S818 in UP-
016 and D21S11 in IN699 (shaded cells in Table 2), 98% (294/300) of the STR markers 
analysed amongst three experiments showed ±1-3bp difference in their sizes, indicating an 
excellent reproducibility of the Bioanalyzer in FLA analysis (Table 2). Interestingly, 
fragment sizes revealed in Exp. 3 were slightly larger in general for the majority of samples 
compared with those in Exp.s 1 & 2 (Table 2), caused by slightly variable electrophoresis 
migration rates in those assays; however, due to the same trend of sizing differences 
demonstrated by all STR markers (instead of only one or two markers), the whole STR 
profile was maintained despite slight shifting of the profile between different experiments. 
Hence all cell lines showed highly identical DNA profiles from three independent 
experiments, as represented by IN699 and SNB-19 (Fig. 2A & B).       
 
Consistent DNA profiling of cell line over multiple subcultures 
Cross-contamination in cell culture invalidates research results and compromises the 
comparison between laboratories. To further validate the application of the microfluidic 
system in cell line DNA profiling and to detect possible cross-contamination during long-
term cell culture, the same STR-based cell identity test was carried out with five genomic 
DNA samples collected from each of the two brain tumour cell lines, i.e. UP-029 and 
SEBTA-003, with 5-passage interval respectively. As the data indicated, each cell line 
showed consistent STR profiles throughout five different passage numbers with ±1-3bp 
difference in sizing amongst 10 markers  (Table 3A & B), suggesting that no cross-
contamination occurred during the in vitro culture period and each cell line had maintained its 
unique DNA fingerprint. The overlaid DNA profiles of 5 different passages further confirmed 
the identical STR fingerprints of the cells (Fig. 3A & B). In accordance with the initial DNA 
profiling data, the sizing of all 10 markers in the cross-contamination test showed ±1-3bp 
difference amongst different passages (Table 3A & B). Therefore, our data indicate that DNA 
profiling by microfluidic electrophoresis could be an effective approach to monitoring cross-
contamination over time and subcultures. Notably, UP-029 was also included in the first part 
of this DNA fingerprinting study where a different Agilent DNA 1000 kit was used, and the 
profile of UP-029 cells maintained excellent similarity throughout different experiments/kits. 
These data provide further evidence for the reliability of this method and the Agilent assay 
kits in the application of cell line authentication.      
 In addition, the StemElite ID System used in this study also incorporates a sensitive 
mouse marker that can be detected after multiplex PCR should the sample contain genomic 
DNA from mouse;
15
 and the data suggest that no mouse contamination was detected in all 
cell lines analysed in the present study (data not show). 
 
Discussion 
The present study demonstrated a new application of the microfluidics-based electrophoresis 
method in STR-based DNA profiling of human cell lines, as shown here with brain tumour 
and brain tissue related cell lines. In this study, the Agilent 2100 Bioanalyzer was used to 
analyse the STR fragments and compared with the standard capillary electrophoresis method. 
Since its launch in 1999, the Bioanalyzer has been utilised for quality check and 
quantification of DNA and RNA samples before downstream applications such as sequencing 
and microarray analyses.
11, 25-28
 Due to its capacity of separating multiple DNA fragments 
within the same sample, it has been utilised in STR-based DNA genotyping of forensic 
samples.
13 
The Agilent 2100 Bioanalyzer offers a broad range of pre-validated analysis kits, 
including the DNA 1000 chip that was used in this study. This DNA chip provides 5-25bp 
sizing resolution for fragments of 100-500bp.
17
 The size range of the STR markers in the 
StemElite ID System is between 90 to 400bp;
15
 therefore it had been speculated that those 
amplified alleles would be separated on the DNA 1000 chip. Notably, the StemElite ID 
System is designed specifically for FLA by the Applied Biosystems capillary electrophoresis 
instruments, e.g. the ABI 3130 and 3130xl Genetic Analyzer.
15
 Here our data demonstrate 
that this cell identification kit is valid for use with a microfluidic chip system, the Agilent 
2100 Bioanalyzer. The STR profiles obtained from both FLA methods were highly 
comparable in this study, despite some discrepancies in the heterozygosity of several markers 
(Table 1A; shaded cells). This could have been caused by unbalanced PCR amplification of 
those markers, i.e. one allele was preferentially amplified than the other, and therefore the 
Bioanalyzer failed to detect the other allele due to low sample concentration whereas the 
capillary electrophoresis system was able to capture the fluorescent signal and detect the 
labelled fragment. The multiplex PCR in this study was performed according to the 
manufacturer’s protocol for the StemElite ID System15 but in the future analyses, the 
amplification parameters could be modified in order to enhance balanced amplification of the 
markers and subsequently improve the resolution of this novel method in detecting 
heterozygous alleles. Notably, only 8% (8/100) of the total markers analysed showed a 
discrepancy in the heterozygosity between the new and conventional methods and this had 
not affected the unique profile of each cell line studied (Table 1A). 
In summary, the microfluidic system produced highly accurate and reproducible DNA 
profiling data from 10 different cell lines demonstrated in the present study, suggesting a new 
approach to cell line authentication using this platform. Furthermore, the comparison analysis 
featured by the Bioanalyzer 2100 Expert software allows a quick fingerprint check for 
different DNA samples from the same cell line by overlaying DNA profiles from either 
independent or the same DNA chip assays, as demonstrated in Fig.s 2 and 3. This analysis 
can also be performed for any two cell lines in order to compare and confirm their different 
profiles, as illustrated in Fig. 1C for TE-671 and UP-019 showing distinct profile of each cell 
line. This could provide a reliable and cost-efficient downstream method for STR-based cell 
line identity check in a cell culture laboratory. 
 It has been fully recognised that routine identity check should be conducted for 
human cell line cultures and recently the importance of cell line verification prior to scientific 
publication has been reiterated by Anja Torsvik et al,
 
as the authors discovered that the 
previously reported spontaneous transformation of human mesenchymal stem cells was in 
fact caused by cell line cross-contamination.
29
 Their report also sheds new light on the urgent 
need for cell validation test of primary cell cultures for therapeutic purposes.
29
 In the present 
study, the microfluidics-based method was employed to monitor possible cross-
contamination over long-term culture period and an excellent accuracy of this novel method 
was illustrated by the identical DNA profiles obtained from different passages of the same 
cell line (Table 3 & Fig. 3), indicating the potential of this method as a more effective 
alternative for cross-contamination check. However, further studies need to be carried out to 
evaluate and compare the sensitivity and specificity of both FLA methods in terms of 
detecting cross-contamination, using carefully designed mixed cell cultures to represent the 
most common contamination scenarios.       
Recently new standards for cell line authentication using STR fingerprinting has been 
proposed.
1-5,30
 It is critical that an internationally standardized STR panel is applied in the cell 
line identity test. The StemElite ID System employed in this study comprises 9 STR markers 
which are in accordance with the markers utilised by ATCC and DSMZ, allowing 
comparison of the fingerprints of our NCI-H1299 and SNB-19 cells with those in the above 
large databases. Notably, a recent study by Pierre Bady and colleagues suggests that the 
commonly used similarity score of 0.8 is not sufficiently stringent to differentiate the origin 
of a cell line based on its DNA fingerprint consisting of only 9 STR loci
26
 and it was 
proposed that the number of STR markers measured should be expanded or to include 
additional cell line characteristics, e.g. specific mutations.
31 
 The focus of this current study 
was to evaluate an alternative method for the standard fragment length analysis by capillary 
electrophoresis, which is time-consuming and costly for most laboratories. Both methods, 
however, are adaptable for expansion of STR markers. The DNA fingerprints of two 
commercially available cell lines recruited in the present study, i.e. NCI-H1299 and SNB-19, 
demonstrated 100% similarity in comparison with the 9-marker fingerprint database of 
ATCC and DSMZ, confirming the origins of those cell lines held in our laboratories. The 
DNA profile of CC2565, another commercially available cell line analysed in this study, was 
compared with the DSMZ database with no matching profile revealed (data not shown), 
indicating that the STR profile of CC2565 is not included in this database. Each of the 7 “in-
house” cell lines presented in this study showed a unique DNA profile, suggesting that the 9-
marker approach was sufficient to identify and differentiate those biopsy-derived cultures.  
It is likely that there will be a need in the future to expand the panel of STR markers 
with increasing number of ‘in house’ cell lines to be tested and this method will 
accommodate this need. We have shown that this microfluidics-based electrophoresis 
platform could provide a more straightforward and cost-effective method for STR-based cell 
line authentication test in our hands, compared with the standard capillary electrophoresis for 
DNA fragment length analysis. It is our hope that this novel application may promote an 
increase in the routine cell line validation test not only by cell bank repositories and 
distributors, but also by the research community.  In addition this method could be useful in a 
broader range of applications, e.g. testing human cancer cells directly passaged and 
maintained in vivo using mouse xenograph models and validating cells used in clinical cell 
therapies. It is also our intention to apply this method in our future studies to address several 
key research questions, in particular with regard to monitoring genetic instability caused by in 
vitro culture, assessing cross-contamination susceptibility levels in different cell lines and 
developing personalised medicine.
Funding: This work was supported by the brain tumour charities Brain Tumour Research 
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Figure legends 
Fig. 1. Representative single (A & B) and comparison (C) electropherograms of DNA 
profiling by a microfluidic system, the Agilent 2100 Bioanalyzer. STR profiles of the cell 
lines TE-671 (A) and UP-019 (B) are illustrated as DNA electrophoresis traces here. 
Fragments of the PCR-amplified STR markers are separated based on their sizes and the size 
of each peak is labelled above it in panels A and B. The overlaid traces of TE-671 and UP-
019 in panel C, obtained from the “Comparison” analysis (Agilent 2100 Expert software), 
show the unique STR profiles of these two cell lines.    
Fig. 2. Overlaid DNA profiles of IN699 (A) and SNB-19 (B) from three independent 
analyses by the microfluidic system. All cell lines analysed in the three independent 
experiments showed reproducible STR profiles, in particular between Exp.1 and Exp.2, as 
represented by IN699 and SNB-19.   
Fig. 3. Overlaid DNA profiles of UP-029 (A) and SEBTA-015 (B) from 5 continuous 
passage numbers, showing the identical profile throughout different passages.  
